Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-156667
Filing Date
2023-05-30
Accepted
2023-05-30 16:48:58
Documents
1
Group Members
JAY SCHMELTERJOHN P. MCKEARN, PH.D.NIALL O'DONNELL, PH.D.RIVERVEST VENTURE FUND III (OHIO), L.P.RIVERVEST VENTURE FUND IV, L.P.RIVERVEST VENTURE PARTNERS III (OHIO), LLCRIVERVEST VENTURE PARTNERS III, L.P.RIVERVEST VENTURE PARTNERS III, LLCRIVERVEST VENTU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d468726dsc13da.htm SC 13D/A 275205
  Complete submission text file 0001193125-23-156667.txt   277211
Mailing Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105
Business Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105 314-726-6700
RiverVest Venture Fund III, L.P. (Filed by) CIK: 0001601559 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91764 | Film No.: 23977256
SIC: 2834 Pharmaceutical Preparations